Two Views Of Risk When Choosing An IRT/RTSM Software Partner

Smaller biotech companies face unique challenges in clinical trial execution — and that extends to their RTSM software needs. In this clip, Ryan Keane of Korio explains why legacy RTSM vendors, designed for large pharmaceutical companies, often struggle to serve smaller, fast-moving Sponsors. Keane discusses the importance of aligning with a provider that matches your organization’s pace, flexibility, and attention to detail. For emerging biotechs, choosing the right RTSM system can make the difference between smooth execution and unnecessary complexity.